These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 9459175
1. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53. Christodoulopoulos G, Fotouhi N, Krajewski S, Reed JC, Alaoui-Jamali M, Panasci L. Cancer Lett; 1997 Dec 16; 121(1):59-67. PubMed ID: 9459175 [Abstract] [Full Text] [Related]
2. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A. Leuk Lymphoma; 1997 Aug 16; 26(5-6):435-49. PubMed ID: 9389352 [Abstract] [Full Text] [Related]
3. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, Newcomb EW. Oncogene; 1996 Mar 07; 12(5):1055-62. PubMed ID: 8649796 [Abstract] [Full Text] [Related]
4. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B, Daniel PT. Leukemia; 2002 Jun 07; 16(6):1035-44. PubMed ID: 12040435 [Abstract] [Full Text] [Related]
5. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs. Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A, Brugiatelli M. Haematologica; 1997 Jun 07; 82(1):16-20. PubMed ID: 9107076 [Abstract] [Full Text] [Related]
6. Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak. Melarangi T, Zhuang J, Lin K, Rockliffe N, Bosanquet AG, Oates M, Slupsky JR, Pettitt AR. Cell Death Dis; 2012 Aug 16; 3(8):e372. PubMed ID: 22898870 [Abstract] [Full Text] [Related]
7. 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Lowdell MW, Samuel ER, North JM, Nacheva EP, Chanalaris A, Kottaridis P, Cwynarski K, Wickremasinghe RG. Blood; 2009 Aug 06; 114(6):1217-25. PubMed ID: 19515722 [Abstract] [Full Text] [Related]
8. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2. Mohammad RM, Beck FW, Katato K, Hamdy N, Wall N, Al-Katib A. Biol Chem; 1998 Oct 06; 379(10):1253-61. PubMed ID: 9820586 [Abstract] [Full Text] [Related]
9. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells. Zhu HJ, Liu L, Fan L, Zhang LN, Fang C, Zou ZJ, Li JY, Xu W. Leuk Lymphoma; 2013 Dec 06; 54(12):2712-9. PubMed ID: 23517560 [Abstract] [Full Text] [Related]
11. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance. Pepper C, Hoy T, Bentley P. Leuk Lymphoma; 1998 Jan 06; 28(3-4):355-61. PubMed ID: 9517506 [Abstract] [Full Text] [Related]
12. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway. Zhou Z, Fang Q, Li P, Ma D, Zhe N, Ren M, Chen B, He Z, Wang J, Zhong Q, Wang J. Life Sci; 2019 Sep 01; 232():116583. PubMed ID: 31226417 [Abstract] [Full Text] [Related]
13. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53. Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR. Blood; 1998 Nov 15; 92(10):3804-16. PubMed ID: 9808574 [Abstract] [Full Text] [Related]
14. Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol. Pepper C, Thomas A, Hoy T, Tighe J, Culligan D, Fegan C, Bentley P. Cell Cycle; 2003 Nov 15; 2(1):53-8. PubMed ID: 12695689 [Abstract] [Full Text] [Related]
19. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage. Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM. Clin Cancer Res; 2002 Aug 15; 8(8):2735-41. PubMed ID: 12171907 [Abstract] [Full Text] [Related]
20. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. Aguilar-Santelises M, Rottenberg ME, Lewin N, Mellstedt H, Jondal M. Int J Cancer; 1996 Apr 22; 69(2):114-9. PubMed ID: 8608978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]